152sek
0,3 %
Date:2025-06-05Time:18:00:00Latest report:Q1-2025List:Small CapTicker:ONCO
Market Cap:344 msekEnterprise Value:355 msekNet Sales:39,8 msekEarnings:-277,5 msekEmployees:0ISIN:SE0009414576

Ratios

10-year key figure history for Oncopeptides turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Oncopeptides with index and moving average MA50 and MA200.

Stockprice:1,52
MA50:1,82
MA200:1,78
Price/MA200:-14,3 %
RSI (14):30,0
Price/MA50:-16,2 %

Description

Oncopeptides is a biotech company that develops drugs for difficult-to-treat hematological diseases. The company uses its PDC platform to develop peptide-linked drugs that selectively deliver cytotoxic drugs into cancer cells. The company has drugs in commercialization and several drug candidates under development. Oncopeptide's head office is located in Stockholm.

Biotechnology